The Relationship Between Obesity and Hypogonadism

Yıl 2025, Cilt: 34 Sayı: 2, 114 - 118, 30.06.2025

Gulfidan Coskun

https://doi.org/10.17827/aktd.1651603

Öz

Obesity is a health problem characterized by excessive fat accumulation in the body, and its prevalence is rapidly increasing in worldwide. The COVID-19 pandemic, movement restrictions, difficulties in accessing medical care, and psychological effects have contributed to the rise in obesity rates. Obesity leads to hormonal imbalances, causing various health problems, particularly hypogonadism in men. The expansion of fat tissue due to obesity directly and indirectly affects testosterone levels, triggering hypogonadism. Fat tissue alters hormone levels through the enzyme aromatase, which converts testosterone into estrogen, and adipokines such as leptin and adiponectin also influence this process. Additionally, low-grade inflammation and oxidative stress associated with obesity impair testosterone production, affecting reproductive functions. Obesity-induced hypogonadism leads to health problems such as muscle and bone loss, along with metabolic and psychological dysfunctions. The effect of obesity on testosterone levels also alters lipid metabolism and body composition, which can further increase fat accumulation. Obesity causes androgen deficiency in men through both direct and indirect pathways, creating physical and psychological health issues.

Anahtar Kelimeler

Obesity , hypogonadism , oxidative stress , ınflammation , adipokines , testosterone

Obezite ve Hipogonadizm İlişkisi

Öz

Obezite, vücutta aşırı yağ birikimiyle karakterize bir sağlık sorunu olup, dünya genelinde prevalansı hızla artmaktadır. COVID-19 pandemisi, hareket kısıtlamaları, tıbbi bakıma erişim zorlukları ve psikolojik etkiler obezite oranlarının yükselmesine katkı sağlamıştır. Obezite, vücutta hormonal dengesizliklere yol açarak çeşitli sağlık sorunlarına, özellikle erkeklerde hipogonadizme neden olabilir. Obeziteye bağlı yağ dokusu genişlemesi, testosteron seviyelerini doğrudan ve dolaylı yollarla etkileyerek hipogonadizmi tetikler. Yağ dokusunun, testosteronu östrojenlere dönüştüren aromataz enzimi aracılığıyla hormon seviyelerini değiştirdiği ve leptin, adiponektin gibi adipokinlerin de bu sürece etkisi olduğu görülmektedir. Ayrıca, obeziteyle ilişkili düşük dereceli enflamasyon ve oksidatif stres de testosteron üretimini bozarak üreme fonksiyonlarını etkiler. Obezite kaynaklı hipogonadizm, metabolik ve psikolojik fonksiyon bozukluklarıyla birlikte kas ve kemik kaybı gibi sağlık problemlerine yol açar. Obezitenin, testosteron seviyeleri üzerindeki etkisi, lipid metabolizmasını ve vücut kompozisyonunu da değiştirir, bu da yağ birikiminin daha da artmasına yol açabilir. Obezite, erkeklerde hem doğrudan hem de dolaylı yollarla androjen eksikliğine neden olarak, hem fiziksel hem de psikolojik sağlık sorunları yaratmaktadır.

Anahtar Kelimeler

Obezite , hipogonadizm , oksidatif stress , enflamasyon , adipokinler , testosteron

Kaynakça

• 1. World Obesity Federation, World Obesity Atlas 2023. Available online: https://www.worldobesity.org/resources/resource-library/world-obesity-atlas-2023. Accessed on 04 Mar 2025.
• 2. Abarca-Gómez L, Abdeen, ZA, Hamid, ZA, Abu-Rmeileh NM, Acosta-Cazares B Acuin C et al. Worldwide Trends in Body-Mass Index, Underweight, Overweight, and Obesity from 1975 to 2016: A Pooled Analysis of 2416 Population-Based Measurement Studies in 1289 Million Children, Adolescents, and Adults. Lancet 2017;390:2627–2642.
• 3. World Health Organisation Global Health Observatory (GHO) Data: Overweight and Obesity. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed on 04 Mar 2025.
• 4. Lin X, Li H. Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front Endocrinol (Lausanne). 2021;12:706978.
• 5. Cooper AJ, Gupta SR, Moustafa AF, Chao AM. Sex/Gender Differences in Obesity Prevalence, Comorbidities, and Treatment. Curr Obes Rep. 2021 Dec;10(4):458-466.
• 6. Bélanger C, Hould FS, Lebel S, Biron S, Brochu G, Tchernof A. Omental and Subcutaneous Adipose Tissue Steroid Levels in Obese Men. Steroids. 2006;71:674–682.
• 7. Di Nisio A, Sabovic I, De Toni L, Rocca MS, Dall’Acqua S, Azzena B et al. Testosterone Is Sequestered in Dysfunctional Adipose Tissue, Modifying Androgen-Responsive Genes. Int. J. Obes. 2020;44:1617–1625.
• 8. Xu X, Sun M, Ye J, Luo D, Su X, Zheng D et al. The Effect of Aromatase on the Reproductive Function of Obese Males. Horm. Metab. Res. 2017;49:572–579.
• 9. Genchi VA, Rossi E, Lauriola C, D'Oria R, Palma G, Borrelli A et al. Adipose Tissue Dysfunction and Obesity-Related Male Hypogonadism. Int J Mol Sci. 2022 Jul 25;23(15):8194. doi:
• 10. Genchi VA, D’Oria R, Palma G, Caccioppoli C, Cignarelli A, Natalicchio A et al. Impaired Leptin Signalling in Obesity: Is Leptin a New Thermolipokine? Int. J. Mol. Sci. 2021;22:6445.
• 11. Roseweir AK, Kauffman AS, Smith JT, Guerriero KA, Morgan K, Pielecka-Fortuna J et al. Discovery of Potent Kisspeptin Antagonists Delineate Physiological Mechanisms of Gonadotropin Regulation. J. Neurosci. Off. J. Soc. Neurosci. 2009;29:3920–3929.
• 12. Zhao J, Zhai L, Liu Z, Wu S, Xu L. Leptin Level and Oxidative Stress Contribute to Obesity-Induced Low Testosterone in Murine Testicular Tissue. Oxid. Med. Cell. Longev. 2014;2014:190945.
• 13. Bai J, Liu Y, Niu GF, Bai LX, Xu XY, Zhang GZ at al. Relationship between Adiponectin and Testosterone in Patients with Type 2 Diabetes. Biochem. Med. 2011;21:65–70.
• 14. Choubey M, Ranjan A, Bora PS, Baltazar F, Krishna A. Direct Actions of Adiponectin on Changes in Reproductive, Metabolic, and Anti-Oxidative Enzymes Status in the Testis of Adult Mice. Gen. Comp. Endocrinol. 2019;279:1–11.
• 15. Kawai T, Autieri MV, Scalia R. Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity. Am. J. Physiol. Cell Physiol. 2021;320:C375–C391.
• 16. Lephart ED, Baxter CR, Parker CR. Effect of Burn Trauma on Adrenal and Testicular Steroid Hormone Production. J. Clin. Endocrinol. Metab. 1987;64:842–848.
• 17. Russell SH, Small CJ, Stanley SA, Franks S, Ghatei MA, Bloom SR. The in Vitro Role of Tumour Necrosis Factor-Alpha and Interleukin-6 in the Hypothalamic-Pituitary Gonadal Axis. J. Neuroendocrinol. 2001;13:296–301.
• 18. Laaksonen D, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen T, Salonen R et al. Sex Hormones, Inflammation and the Metabolic Syndrome: A Population-Based Study. Eur. J. Endocrinol. 2003;149:601–608..
• 19. Barbagallo F, Condorelli RA, Mongioì LM, Cannarella R, Cimino L, Magagnini MC et al. Molecular Mechanisms Underlying the Relationship between Obesity and Male Infertility. Metabolites. 2021;11(12):840.
• 20. Ahn SW, Gang GT, Kim YD, Ahn RS, Harris RA, Lee CH et al. Insulin directly regulates steroidogenesis via induction of the orphan nuclear receptor DAX-1 in testicular Leydig cells. J Biol Chem. 2013;288(22):15937-15946.
• 21. Davidson LM, Millar K, Jones C, Fatum M, Coward K. Deleterious effects of obesity upon the hormonal and molecular mechanisms controlling spermatogenesis and male fertility. Hum Fertil (Camb). 2015;18(3):184-193.
• 22. Engin A. Adipose Tissue Hypoxia in Obesity and Its Impact on Preadipocytes and Macrophages: Hypoxia Hypothesis. Adv. Exp. Med. Biol. 2017;960:305–326.
• 23. Manna P, Jain SK. Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies. Metab. Syndr. Relat. Disord. 2015;13:423–444.
• 24. Roychoudhury S, Chakraborty S, Choudhury AP, Das A, Jha NK, Slama P et al. Environmental Factors-Induced Oxidative Stress: Hormonal and Molecular Pathway Disruptions in Hypogonadism and Erectile Dysfunction. Antioxidants (Basel). 2021;10:837.
• 25. Cartledge J, Minhas S, Eardley I. The Role of Nitric Oxide in Penile Erection. Expert Opin. Pharmacother. 2001;2:95–107.